Michael Andrew Williams (Michael A Williams, Michael Williams, M A Williams, M Williams)

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 13

Top Topics

Diffusion Weighted

Systematic Review

Vascular Endothelial Growth Factor

Diabetic Retinopathy

Top Venues

Eye (London, England)

BMJ open ophthalmology

The British journal of ophthalmology

This page only lists publications with an associated author ORCID identifier.

Publications

Michael Andrew Williams
Ophthalmic education in universities. Eye (London, England) (2023)
Chris Jacobs, Georgia Foote, Michael Andrew Williams
Evaluating user experience with immersive technology in simulation-based education: A modified Delphi study with qualitative analysis. PloS one 18 (8) (2023)
Chris Irwin, Michael Andrew Williams
The environmental impact of treating macular disease. Eye (London, England) (2023)
Michael Andrew Williams
Virtual reality in ophthalmology education: simulating pupil examination. Eye (London, England) 36 (11) (2022)
Alexandra Hunter, Michael Andrew Williams
Long-term outcomes for patients treated for macular oedema secondary to retinal vein occlusion: a systematic review. BMJ open ophthalmology 7 (1) (2022)
Gerard A Reid, Michael Andrew Williams, Marie Compton, Giuliana Silvestri, Clara McAvoy
Ocular sarcoidosis prevalence and clinical features in the Northern Ireland population. Eye (London, England) (2021)
A Heaney, E McLoone, Michael Andrew Williams, G Silvestri, A E Courtney, D O'Rourke, C E McAvoy
Tubulointerstitial nephritis and uveitis in Northern Ireland. Eye (London, England) (2021)
Richard P Gale, Ian Pearce, Nicole Eter, Faruque Ghanchi, Frank G Holz, Steffen Schmitz-Valckenberg, Konstantinos Balaskas, Ben J L Burton, Susan M Downes, Haralabos Eleftheriadis, Sheena George, David Gilmour, Robin Hamilton, Andrew J Lotery, Nishal Patel, Priya Prakash, Cynthia Santiago, Saju Thomas, Deepali Varma, Gavin Walters, Michael Andrew Williams, Armin Wolf, Rosina H Zakri, Franklin Igwe, Filis Ayan
Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study. The British journal of ophthalmology 104 (4) (2019)
Mary-Therese Monaghan, Claire Steenson, Michael Andrew Williams
Re: Understanding quality of life impact in people with retinal vein occlusion: a qualitative inquiry. Clinical & experimental optometry 102 (5) (2019)
Michael Andrew Williams, Augusto Azuara Blanco, Ruth Hogg, Gerry Mahon, Margaret McMullan, Raymond Curran, Max Watson
Creating a virtual community of practice: an evaluation of ophthalmology-optometry Project ECHO. Eye (London, England) 32 (12) (2018)
W McCague, V Silvestri, P Passmore, G Silvestri, Michael Andrew Williams
Beta-atrophy in Alzheimer's disease. Eye (London, England) 31 (9) (2017)
Michael Andrew Williams, Mairead Boohan, Allen Thurston
Scoping systematic review on the extent, nature and quality of evidence underlying ophthalmic and paraophthalmic education. Evidence-based medicine 22 (1) (2016)
Michael Andrew Williams, Catherine Ross, Sonia Derbyshire, Stephen Duffy, Clare Morgan, Michael O'Gallagher, James Murray
Simulated eye clinic and virtual eye case: alternative worlds for medical students. BMJ simulation & technology enhanced learning 2 (4) (2016)